[Glucocorticoid and Bone. The inhibition of osteoblast differentiation and induction of osteocyte apoptosis through the regulation of Bcl-2 by glucocorticoids].
Takeshi Moriishi, Toshihisa Komori
Abstract
Takeshi Moriishi, Toshihisa Komori
Abstract
Glucocorticoid-induced osteoporosis is caused by the inhibition of osteoblast differentiation and induction of osteoblast and osteocyte apoptosis. Glucocorticoids inhibit osteoblast differentiation by reducing the expression of Wnt signaling proteins, osteocalcin, and AP-1. Further, glucocorticoids induce osteoblast and osteocyte apoptosis by regulating the expression of Bcl-2 family proteins. Apoptotic signaling enhances osteoblast differentiation, at least in part, through FoxO. However, FoxO is also likely to be involved in the inhibition of osteoblast differentiation by glucocorticoids.
OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Glucocorticoid-induced osteoporosis is caused by the inhibition of osteoblast differentiation and induction of osteoblast and osteocyte apoptosis. Glucocorticoids inhibit osteoblast differentiation by reducing the expression of Wnt signaling proteins, osteocalcin, and AP-1. Further, glucocorticoids induce osteoblast and osteocyte apoptosis by regulating the expression of Bcl-2 family proteins. Apoptotic signaling enhances osteoblast differentiation, at least in part, through FoxO. However, FoxO is also likely to be involved in the inhibition of osteoblast differentiation by glucocorticoids.
Key concepts: Osteocyte, Osteoblast, Osteocalcin, Cell biology, Glucocorticoid, Chemistry, Apoptosis, Internal medicine